JBIO vs ELVN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

JBIO

52.1
AI Score
VS
ELVN Wins

ELVN

56.0
AI Score

Investment Advisor Scores

JBIO

52score
Recommendation
HOLD

ELVN

56score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric JBIO ELVN Winner
Net Income -40.37M -23.63M ELVN
Operating Income -43.45M -27.82M ELVN
ROE -13.6% -5.2% ELVN
ROA -12.6% -5.1% ELVN
Total Assets 319.43M 464.85M ELVN
Cash 55.09M 132.18M ELVN
Current Ratio 14.29 40.32 ELVN

Relative Price Performance (Last 90 Days)

JBIO 1M: -11.0% · 3M: -21.0% ELVN 1M: +16.5% · 3M: +39.2%

Current Technical Phase

JBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.3%), weak momentum, RSI 42

RSI (14): 42.1 · Price: $19.15

ELVN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (10.2% over 20 days), RSI 70

RSI (14): 70.0 · Price: $58.04

Fundamentals Snapshot

Metric JBIO ELVN
Market Cap
Forward P/E -8.7 -25.0
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin
Operating Margin 0.0% 0.0%
EPS -2.72 -1.64
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ELVN is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.